O
Description
OxyPharma AB is a Swedish pharmaceutical company headquartered in Stockholm dedicated to the discovery and development of new drugs, with a primary focus on the treatment of rheumatoid arthritis and multiple sclerosis. The company has had at least one candidate (Rob 803) in a Phase II clinical trial for rheumatoid arthritis. It is a small company with activity primarily in early research.